SCHEMBL30925408

SCHEMBL30925408

Cc1cccnc1S(=O)(=O)Nc1cccc2c1CN(C1CC1)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ SLC40A1 Q9NP59 3/20 0.37
▸ LMNA P02545 5/20 0.36
▸ NPSR1 Q6W5P4 4/20 0.36
▸ RECQL P46063 1/20 0.36
▸ HTT P42858 4/20 0.35
▸ GAA P10253 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ KMT2A Q03164 4/20 0.34
▸ TDP1 Q9NUW8 3/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ HTR6 P50406 3/20 0.34
▸ MITF O75030 1/20 0.33
▸ S1PR4 O95977 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ S1PR1 P21453 1/20 0.33
▸ AGTR1 P30556 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ CKS1B P61024 1/20 0.33
▸ SKP2 Q13309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30925503 0.91 SLC40A1 (0.39) ALDH1A1SLC40A1LMNANPSR1HTT
SCHEMBL29800820 0.85 ALDH1A1 (0.43) ALDH1A1SLC40A1LMNANPSR1RECQL
SCHEMBL26964182 0.85 ALDH1A1 (0.43) ALDH1A1SLC40A1LMNANPSR1RECQL
SCHEMBL26964299 0.82 NPSR1 (0.44) ALDH1A1SLC40A1LMNANPSR1RECQL
SCHEMBL29800777 0.79 SLC40A1 (0.42) ALDH1A1SLC40A1LMNANPSR1HTT
SCHEMBL26964253 0.79 SLC40A1 (0.42) ALDH1A1SLC40A1LMNANPSR1HTT
SCHEMBL29800729 0.78 TP53 (0.38) ALDH1A1SLC40A1LMNANPSR1HTT
SCHEMBL30925540 0.78 HTR6 (0.36) ALDH1A1SLC40A1LMNANPSR1HTT
SCHEMBL26964478 0.78 TP53 (0.38) ALDH1A1SLC40A1LMNANPSR1HTT
SCHEMBL29800811 0.77 SCN9A (0.44) LMNANPSR1RECQLHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240148744-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES ZOETIS LLC 2024-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240148744-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES ARSA, MRPS2, SULT2A1 ALDH1A1 1470/4885SLC40A1 3357/4885LMNA 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback